newsfilter
← Latest News
Business Wire·

Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

- Strengthened Board and management with appointments of experienced biotech leaders Troy Ignelzi, Sarah Boyce, John Healy and Kristina Haeckl - - Strong cash position of $219 million at the end of Q2 will support